RT Journal Article
SR Electronic
T1 The mortality due to COVID-19 in different nations is associated with the demographic character of nations and the prevalence of autoimmunity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.31.20165696
DO 10.1101/2020.07.31.20165696
A1 Chatterjee, Bithika
A1 Karandikar, Rajeeva Laxman
A1 Mande, Shekhar C.
YR 2020
UL http://medrxiv.org/content/early/2020/10/19/2020.07.31.20165696.abstract
AB In the first few months of its deadly spread across the world, Covid-19 mortality has exhibited a wide range of variability across different nations. In order to explain this phenomenon empirically, we have taken into consideration all publicly available data for 106 countries on parameters like demography, prevalence of communicable and non-communicable diseases, BCG vaccination status, sanitation parameters etc. We ran multivariate linear regression models to find that the incidence of communicable diseases correlated negatively while demography, improved hygiene and higher incidence of autoimmune disorders correlated positively with Covid-19 mortality and were among the most plausible factors to explain Covid-19 mortality as compared to the GDP of the nations.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNo clinical trialsFunding StatementBC gratefully acknowledges financial support by the National Centre for Cell Science, Pune. Authors declare no competing financial interests.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No clinical studies performed. Publicly available data was usedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesdataset is available for data.